A global database of COVID-19 vaccinations.

@article{Mathieu2021AGD,
  title={A global database of COVID-19 vaccinations.},
  author={Edouard Mathieu and Hannah Ritchie and Esteban Ortiz-Ospina and Max Roser and Joe Hasell and Cameron Appel and Charlie Giattino and Lucas Rod{\'e}s-Guirao},
  journal={Nature human behaviour},
  year={2021}
}
An effective rollout of vaccinations against COVID-19 offers the most promising prospect of bringing the pandemic to an end. We present the Our World in Data COVID-19 vaccination dataset, a global public dataset that tracks the scale and rate of the vaccine rollout across the world. This dataset is updated regularly and includes data on the total number of vaccinations administered, first and second doses administered, daily vaccination rates and population-adjusted coverage for all countries… 
Usefulness of Electoral Models for COVID-19 Vaccine Distribution
In response to the COVID-19 pandemic, there has been a remarkably accelerated development of vaccines worldwide. However, an effective distribution system is crucial for vaccination at a national
Global diversity of policy, coverage, and demand of COVID-19 vaccines: a descriptive study
TLDR
There is wide country-level disparity and inequity in COVID-19 vaccines rollout, suggesting large gaps in immunity, especially in low-income countries.
Global diversity of policy, coverage, and demand of COVID-19 vaccines: a descriptive study
TLDR
There is wide country-level disparity and inequity in COVID-19 vaccines rollout, suggesting large gaps in immunity, especially in low-income countries.
The Effect of the COVID-19 Vaccine on Daily Cases and Deaths Based on Global Vaccine Data
TLDR
Vaccination can effectively reduce the new cases and deaths of COVID-19, but vaccines are not distributed fairly worldwide, and there is an urgent need to accelerate the speed of vaccination and promote its fair distribution across countries.
Progress of the COVID-19 vaccine effort: viruses, vaccines and variants versus efficacy, effectiveness and escape
TLDR
A snapshot of ongoing vaccine efficacy studies, as well as real-world data on vaccine effectiveness and the impact of virus variants of concern are provided.
A systematic review of COVID-19 vaccine efficacy and effectiveness against SARS-CoV-2 infection and disease
TLDR
A systematic review of COVID-19 vaccines as of August 2021, which includes efficacy data from Phase 3 clinical trials for 13 vaccines within the WHO Emergency Use Listing evaluation process and real-world effectiveness for 5 vaccines with observational studies meeting inclusion criteria.
Global COVID-19 Vaccine Inequity: Failures in the First Year of Distribution and Potential Solutions for the Future
Within the first year of distribution of vaccines against COVID-19, high-income countries (HICs) have achieved vaccination rates of 75-80%, whilst low-income countries (LICs) vaccinated <10%. This
China’s COVID-19 Vaccination Strategy and Its Impact on the Global Pandemic
TLDR
Considering the impact of China's high vaccination rate on the global pandemic, it is argued that it has strengthened China’s opportunities and capabilities to participate in global development, enhanced the equity of vaccines and given the world community more choices.
The Importance of Vaccination in the Context of the COVID-19 Pandemic: A Brief Update Regarding the Use of Vaccines
TLDR
The updated scenario regarding SARS-CoV-2 variants and COVID-19 vaccines is described and current discussions covering CO VID-19 vaccine safety and efficacy are outlined, and the future pandemic perspectives are outlined.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 11 REFERENCES
Looking beyond COVID-19 vaccine phase 3 trials.
After the recent announcement of COVID-19 vaccine efficacy in clinical trials by several manufacturers for protection against severe disease, a comprehensive post-efficacy strategy for the next steps
Israel’s rapid rollout of vaccinations for COVID-19
TLDR
Part of what made the Israeli rollout of COVID-19 vaccinations successful was its combination of facilitating factors (as opposed to each factor being unique separately) and the synergies it created among them.
A global panel database of pandemic policies (Oxford COVID-19 Government Response Tracker).
TLDR
The Oxford COVID-19 Government Response Tracker (OxCGRT) is introduced, a dataset that addresses the need for continuously updated, readily usable and comparable information on policy measures and enables researchers and policymakers to explore the empirical effects of policy responses on the spread of CO VID-19 cases and deaths.
A cross-country database of COVID-19 testing
TLDR
This new database brings together official data on the extent of PCR testing over time for 94 countries and aims to facilitate the incorporation of this crucial information into epidemiological studies, as well as track a key component of countries’ responses to COVID-19.
Who should be vaccinated first? Comparing vaccine prioritization strategies in Israel and European countries using the Covid-19 Health System Response Monitor
TLDR
It is argued that following the Israeli approach of using broad criteria for prioritization could have several beneficial effects, including more manageable logistics and fewer roll out delays, as well as potentially reducing pressure on hospitals.
Factors Associated With US Adults’ Likelihood of Accepting COVID-19 Vaccination
TLDR
It is found that vaccine-related attributes and political factors were associated with preferences for choosing a hypothetical COVID-19 vaccine, and health care attitudes and practices, political partisanship, and demographic characteristics were also associated with willingness to receive a vaccination.
COVID-19 vaccination intention in the UK: results from the COVID-19 vaccination acceptability study (CoVAccS), a nationally representative cross-sectional survey
TLDR
Intention to be vaccinated was associated with more positive general COVID-19 vaccination beliefs and attitudes, weaker beliefs that the vaccination would cause side effects or be unsafe, greater perceived information sufficiency to make an informed decision about COVID/19 vaccination, and having been vaccinated for influenza last winter (2019/20).
Covid-19 vaccination: What’s the evidence for extending the dosing interval?
On 30 December the four UK chief medical officers announced that the second doses of the covid vaccines should be given towards the end of 12 weeks rather than in the previously recommended 3-4
Restoring confidence in vaccines in the COVID-19 era
TLDR
A large number of vaccine hesitancy cases are associated with at-risk children under the age of six months, and the number of cases is likely to increase in the coming years.
Covid-19: How the UK vaccine rollout delivered success, so far
Chris Baraniuk explains the elements that have made the UK’s vaccination programme a front runner globally and describes the hurdles that lie ahead
...
1
2
...